Medscape: Cannabis drug promising for seizures linked to tuberous sclerosis
UC epilepsy expert weighs in on use of cannabis and CBD oil for seizures
An oral formulation of highly purified cannabidiol, or CBD, reduces seizures associated with tuberous sclerosis complex by more than one third, results of a phase 3 multisite randomized trial show.
A rare genetic disorder, TSC is characterized by benign tumors that develop in many parts of the body, including the brain, where they can trigger seizures. Seizures in young children, which manifest as repetitive spasm of the head and legs, are often the presenting symptom of the disease.
Dr. Michael Privitera, professor at UC, UC Health physician and director of the Epilepsy Center at the University of Cincinnati Gardner Neuroscience Institute, said the study "is important because it provides evidence from a rigorous randomized controlled trial that broadens the uses of cannabidiol in epilepsy."
Tags
Related Stories
Cincinnati Enquirer: Behind the ventilator, specialists provide breaths for COVID-19 patients
April 21, 2020
Suzanne Bennett, MD, associate professor in the UC College of Medicine and UC Health anesthesiologist and critical care physician, spoke to the Cincinnati Enquirer for a story about ventilators, their operators and their roles in the COVID-19 pandemic. She said the respiratory therapists can be the lifesavers for some COVID-19 patients.